![<?echo $_SERVER['SERVER_NAME'];?>](/template/twentyseventeen/skin/images/header.jpg)
The successful development of the lily bulb sorting line has improved the accuracy and efficiency of the lily bulb sorting, which has improved the classification efficiency by more than 3 times and reduced the labor cost to half of the previous one. Compared with the foreign ball sorting line, the lily ball sorting line developed by Gesang Flower Company has three advantages: First, cleaning and grading are completed at the same time, and can be divided into 8 levels at a time (the ball diameter is from 6 cm to ～ 8 cm to 20 cm or more), can handle 50,000 to 60,000 bulbs a day; second, mechanical damage to the bulb is not large, to ensure the quality of the bulb; third, the cost is low, each cost is less than 10,000 yuan It is very suitable for promotion and use in China.
Rucaparib is an orally bioavailable tricyclic indole and inhibitor of poly(ADP-ribose) polymerases (PARPs) 1 (PARP1), 2 (PARP2) and 3 (PARP3), with potential chemo/radiosensitizing and antineoplastic activities. Upon administration, rucaparib selectively binds to PARP1, 2 and 3 and inhibits PARP-mediated DNA repair. This enhances the accumulation of DNA strand breaks, promotes genomic instability and induces cell cycle arrest and apoptosis. This may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. PARPs are enzymes activated by single-strand DNA breaks that catalyze the post-translational ADP-ribosylation of nuclear proteins, which induces signaling and the recruitment of other proteins to repair damaged DNA. The PARP-mediated repair pathway plays a key role in DNA repair and is dysregulated in a variety of cancer cell types.
Rucaparib Cas 78902-09-7,Rucaparib Cas 2913-97-5,Rucaparib Intermediate Cas 78902-09-7,Rucaparib Intermediate Cas 2913-97-5
 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com